Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank25
3Y CAGR-50.3%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
-50.3%/yr
Annual compound
Percentile
P25
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20251.21-15.2%
20241.43+125.0%
2023-5.73-158.1%
20229.86+56.8%
20216.28-